Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
Search /vufind/Search2/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
PubPharm (12)
1
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC
enthalten in:
The New England journal of medicine
| 2023
von
Zhou, C.
|
Solomon, B.
|
Loong, H.
| +122
CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF8. - PMID 37874126
Wird geladen...
2
Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Yang, Y.
|
Sun, J.
|
Wang, Z.
| +28
Wird geladen...
3
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC : a multicenter phase-II trial
enthalten in:
Signal transduction and targeted therapy
| 2021
von
Jiang, T.
|
Wang, P.
|
Zhang, J.
| +22
Wird geladen...
4
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304) : A Randomized Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Lu, S.
|
Wang, J.
|
Yu, Y.
| +19
CommentIn: J Thorac Oncol. 2021 Sep;16(9):1434-1436. - PMID 34425995
Wird geladen...
5
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC : Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Zhou, C.
|
Wu, L.
|
Fan, Y.
| +23
CommentIn: J Thorac Oncol. 2021 Sep;16(9):1434-1436. - PMID 34425995
Wird geladen...
6
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer : KEYNOTE-042 China Study
enthalten in:
International journal of cancer
| 2021
von
Wu, Y.
|
Zhang, L.
|
Fan, Y.
| +14
Wird geladen...
7
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer : A Phase 3 Randomized Clinical Trial
enthalten in:
JAMA oncology
| 2021
von
Wang, J.
|
Lu, S.
|
Yu, X.
| +17
CommentIn: JAMA Oncol. 2021 May 1;7(5):717-719. - PMID 33792622
Wird geladen...
8
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL) : a randomised, open-label, multicentre, phase 3 trial
enthalten in:
The Lancet. Respiratory medicine
| 2021
von
Zhou, C.
|
Chen, G.
|
Huang, Y.
| +34
Wird geladen...
9
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION) : A Multicenter, Two-Stage, Phase 2 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Fan, Y.
|
Zhao, J.
|
Wang, Q.
| +18
Wird geladen...
10
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC : a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2020
von
Yang, Y.
|
Wang, Z.
|
Fang, J.
| +31
CommentIn: J Thorac Oncol. 2020 Oct;15(10):1556-1558. - PMID 32981596
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
5
Journal of thoracic oncology : official publica...
2
The New England journal of medicine
1
International journal of cancer
1
JAMA oncology
1
Lancet (London, England)
1
Signal transduction and targeted therapy
1
The Lancet. Respiratory medicine
Alle anzeigen ...
weniger ...
Thema
Antibodies, Monoclonal, Humanized
12
Journal Article
11
Randomized Controlled Trial
11
Research Support, Non-U.S. Gov't
9
Clinical Trial, Phase III
5
BG3F62OND5
5
Carboplatin
5
Multicenter Study
4
04Q9AIZ7NO
4
Pemetrexed
3
49DFR088MY
3
8FU7FQ8UPK
3
DPT0O3T46P
3
Platinum
3
Sintilimab
3
pembrolizumab
3
sintilimab
2
0KVO411B3N
2
73096E137E
2
Clinical Trial, Phase II
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...